8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The bright future of nanotechnology in lymphatic system imaging and imaging-guided surgery

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Graphical Abstract

          Lymphatic system is identified the second vascular system after the blood circulation in mammalian species, however the research on lymphatic system has long been hampered by the lack of comprehensive imaging modality. Nanomaterials have shown the potential to enhance the quality of lymphatic imaging due to the unparalleled advantages such as the specific passive targeting and efficient co-delivery of cocktail to peripheral lymphatic system, ease molecular engineering for precise active targeting and prolonged retention in the lymphatic system of interest. Multimodal lymphatic imaging based on nanotechnology provides a complementary means to understand the kinetics of lymphoid tissues and quantify its function. In this review, we introduce the established approaches of lymphatic imaging used in clinic and summarize their strengths and weaknesses, and list the critical influence factors on lymphatic imaging. Meanwhile, the recent developments in the field of pre-clinical lymphatic imaging are discussed to shed new lights on the design of new imaging agents, the improvement of delivery methods and imaging-guided surgery strategies.

          Related collections

          Most cited references178

          • Record: found
          • Abstract: not found
          • Article: not found

          Aggregation-induced emission of 1-methyl-1,2,3,4,5-pentaphenylsilole

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Crucial breakthrough of second near-infrared biological window fluorophores: design and synthesis toward multimodal imaging and theranostics.

            The development of fluorophores and molecular probes for the second near-infrared biological window (NIR-II, 1000-1700 nm) represents an important, newly emerging and dynamic field in molecular imaging, chemical biology and materials chemistry. Because of reduced scattering, minimal absorption and negligible autofluorescence, NIR-II imaging provides high resolution, a high signal-to-noise ratio, and deep tissue penetration capability. Among various state-of-the-art bioimaging modalities, one of the greatest challenges in developing novel probes is to achieve both high resolution and sensitivity. The chemical design and synthesis of NIR-II fluorophores suitable for multimodal imaging is thus emerging as a new and powerful strategy for obtaining high-definition images. NIR-II fluorophores may convert NIR-II photons into heat for photothermal therapy and be excited by NIR-II light to produce singlet oxygen for photodynamic therapy. The presence of simultaneous diagnostic and therapeutic capabilities in a single probe can be used for precise treatment. In this review, we have focused on recent advances in the chemical design and synthesis of NIR-II fluorophores from small organic molecules to organic and inorganic nanoparticles, and we have further discussed recent advances and key operational differences in reported NIR-II imaging systems and biomedical applications based on NIR-II imaging, such as multimodal imaging, photothermal and photodynamic therapy, guidance for intraoperative surgery, and drug delivery.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Magnetic nanoparticles in MR imaging and drug delivery.

              Magnetic nanoparticles (MNPs) possess unique magnetic properties and the ability to function at the cellular and molecular level of biological interactions making them an attractive platform as contrast agents for magnetic resonance imaging (MRI) and as carriers for drug delivery. Recent advances in nanotechnology have improved the ability to specifically tailor the features and properties of MNPs for these biomedical applications. To better address specific clinical needs, MNPs with higher magnetic moments, non-fouling surfaces, and increased functionalities are now being developed for applications in the detection, diagnosis, and treatment of malignant tumors, cardiovascular disease, and neurological disease. Through the incorporation of highly specific targeting agents and other functional ligands, such as fluorophores and permeation enhancers, the applicability and efficacy of these MNPs have greatly increased. This review provides a background on applications of MNPs as MR imaging contrast agents and as carriers for drug delivery and an overview of the recent developments in this area of research.
                Bookmark

                Author and article information

                Contributors
                guocanyu@mail.tsinghua.edu.cn
                dujs@jlu.edu.cn
                Journal
                J Nanobiotechnology
                J Nanobiotechnology
                Journal of Nanobiotechnology
                BioMed Central (London )
                1477-3155
                6 January 2022
                6 January 2022
                2022
                : 20
                : 24
                Affiliations
                [1 ]GRID grid.415954.8, ISNI 0000 0004 1771 3349, Key Laboratory & Engineering Laboratory of Lymphatic Surgery Jilin Province, , China-Japan Union Hospital of Jilin University, ; Changchun, 130031 People’s Republic of China
                [2 ]GRID grid.12527.33, ISNI 0000 0001 0662 3178, Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, , Tsinghua University, ; Beijing, 100084 People’s Republic of China
                [3 ]GRID grid.414367.3, Department of Lymphology, , Beijing Shijitan Hospital, Capital Medical University, ; Beijing, 100038 People’s Republic of China
                Author information
                http://orcid.org/0000-0003-1157-4184
                Article
                1232
                10.1186/s12951-021-01232-5
                8740484
                34991595
                7e29c6e4-df43-4615-8dd1-1b93be72e118
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 10 November 2021
                : 28 December 2021
                Funding
                Funded by: Key Laboratory Construction Project of Jilin Province
                Award ID: 20190901002JC
                Award Recipient :
                Funded by: Innovation Building Projects of Jilin Province
                Award ID: 2019C007
                Award Recipient :
                Funded by: Special project for health scientific research talents of Jilin Province
                Award ID: 2020SCZ11
                Award Recipient :
                Funded by: the Tsinghua University Spring Breeze Fund
                Award ID: 2021Z99CFZ007
                Award Recipient :
                Funded by: the Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study
                Award ID: SN-ZJU-SIAS-006
                Award Recipient :
                Categories
                Review
                Custom metadata
                © The Author(s) 2022

                Biotechnology
                lymphatic system imaging,nanotechnology,lymphoscintigraphy,multimodal imaging,imaging-guided surgery

                Comments

                Comment on this article